Skip to main content
Clinical Trials/NCT04449757
NCT04449757
Unknown
N/A

Fluid Resuscitation Management for Patients With Septic Shock: the Efficacy and Safety Comparison Between Bicarbonated Ringer's Solution and Lactated Ringer's Solution

Zhongnan Hospital1 site in 1 country260 target enrollmentJuly 1, 2020

Overview

Phase
N/A
Intervention
Lactated Ringer's solution
Conditions
Septic Shock
Sponsor
Zhongnan Hospital
Enrollment
260
Locations
1
Primary Endpoint
the average doses of vasopressors
Last Updated
5 years ago

Overview

Brief Summary

In this prospective randomized controlled trial, investigators aim to study the effects and safety of bicarbonated Ringer's solution in patients with septic shock compared with lactated ringer's solution, and provide evidence for current fluid resuscitation strategies for septic shock.

Detailed Description

Although the latest guidelines recommend crystalloids as the first choice for the patients' fluid resuscitation, it still remains controversial that which crystalloid solution is the best choice. It is reported that balanced crystalloid can result in better outcomes than saline for critically ill patients. However, there are few studies conducted between different crystalloid solutions. Lactated ringer's solution is the longest-used crystalloid solution. Compared with lactated ringer's solution whose anion is lactate, the anion of bicarbonate ringer's solution is bicarbonate. And lactate needs to be metabolized into bicarbonate through the mitochondria of the liver before it can play an alkalization role. Therefore, in theory, bicarbonate ringer's solution does not need to rely on liver metabolism, the onset time to maintain acid-base balance is shorter, and it may be more suitable for patients with severe acidosis. In patients with septic shock, the incidence of moderate to severe metabolic is increased. Bicarbonate ringer's solution can directly supplement the concentration of bicarbonate, while lactated ringer's solution needs to take time and be metabolized in the liver. Thus, we hypothesize that bicarbonate ringer's solution is more effective for patients with shock and metabolic acidosis than lactated ringer's solution.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
May 30, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Zhongnan Hospital
Responsible Party
Principal Investigator
Principal Investigator

ZhiYong Peng

Professor; Chief physician

Zhongnan Hospital

Eligibility Criteria

Inclusion Criteria

  • At the age of 18 to 75;
  • Being treated in the ICU;
  • Diagnosed as septic shock according tho the definition of Sepsis 3.0 with fluid resuscitation requirement.

Exclusion Criteria

  • Severe hepatic failure;
  • Possible brain injury;
  • With absolute contraindications for central vena catheterization;
  • Ever participated in another clinical trial within 30 days prior enrollment;
  • Have corrected metabolic acidosis through alkaline drug application within 24 hours prior to enrollment;
  • Hypermagnesemia or hypothyroidism;
  • Pregnant of breast-feeding women;
  • Considered inevitable death;
  • Other situations where investigators think enrollment is not appropriate.

Arms & Interventions

lactated ringer's solution

We apply lactated ringer's solution as resuscitation fluid to patients with septic shock.

Intervention: Lactated Ringer's solution

bicarbonated ringer's solution

We apply bicarbonated ringer's solution as resuscitation fluid to patients with septic shock.

Intervention: Bicarbonated Ringer's solution

Outcomes

Primary Outcomes

the average doses of vasopressors

Time Frame: From the onset of shock to the first blood pressure stabilization (MAP≥65mmHg), or serum lactate <2.2mmol/l, or discontinuation of vasoactive drugs. About 24 hours.

total doses of norepinephrine÷weight÷duration of usage

Secondary Outcomes

  • the PH value(0, 3 hours, 6 hours, 12 hours, 24 hours)
  • mortality from any cause(on the day28 after enrollment)
  • the rate of metabolic alkalosis(From the onset of shock to the first blood pressure stabilization (MAP≥65mmHg), or serum lactate <2.2mmol/l, or discontinuation of vasoactive drugs. About 24 hours.)
  • total volume of fluids before hemodynamic stabilization(From the onset of shock to the first blood pressure stabilization (MAP≥65mmHg), or serum lactate <2.2mmol/l, or discontinuation of vasoactive drugs. About 24 hours.)
  • the change of serum lactate value at the 6th hour(6 hours)
  • the BE value(0, 3 hours, 6 hours, 12 hours, 24 hours)
  • shock reversal time(From the onset of shock to the first blood pressure stabilization (MAP≥65mmHg), or serum lactate <2.2mmol/l, or discontinuation of vasoactive drugs. About 24 hours.)
  • the proportion of patients whose serum lactate decreases 30%(From the onset of shock to the first blood pressure stabilization (MAP≥65mmHg), or serum lactate <2.2mmol/l, or discontinuation of vasoactive drugs. About 24 hours.)

Study Sites (1)

Loading locations...

Similar Trials